PACB
NASDAQ · Life Sciences Tools & Services
Pacific Biosciences Of Calif
$1.40
+0.06 (+4.48%)
PACB News6 articles
STB Pauses $85B Rail Merger, Demands More Data from Union Pacific and Norfolk Southern
The STB accepted Union Pacific and Norfolk Southern's revised merger filing but paused the case, demanding more information by July 27. Shares fell 4.2% and 5.4%.
Lockheed Martin Secures $407M Aegis Upgrade for Guam Amid Pacific Defense Surge
Lockheed Martin secures a $407.2M Pentagon contract modification to advance Aegis missile defense for Guam, bringing total project value to about $1.94B. Work runs through December 2029.
Union Pacific Warns It May Walk Away From $85 Billion Norfolk Southern Deal Amid Regulatory Hurdles
Union Pacific may drop its $85 billion Norfolk Southern merger if regulators require major line sales or trackage rights. The STB is reviewing the revised application.
Berkshire Shares Stabilize After Sharp Drop on Earnings, PacifiCorp Risk
Berkshire Hathaway's stock found footing in early trading Tuesday after a significant selloff, as investors digest a 30% drop in operating profit and rising legal liabilities at utility subsidiary PacifiCorp.
Berkshire Shares Stabilize After Sharp Drop on Earnings, PacifiCorp Risk
Berkshire Hathaway's stock found footing in early trading Tuesday, following a steep decline after quarterly operating profit fell 30% and S&P Global flagged a potential junk downgrade for utility subsidiary PacifiCorp.
ICG Shares Dip Amid Asia-Pacific Leadership Appointment
ICG plc shares declined 1.1% in London trading following the appointment of a new Asia-Pacific corporate strategy head. The alternative asset manager reported $127 billion in assets under management.